Alphamab Oncology
Latest round
- Series B
Last raised
- May 2019
Total raised
- $160M
Investors
- 7
About Alphamab Oncology
Founded in 2015 and based in Jiangsu, China, Alphamab Oncology is a biopharmaceutical company that develops and manufactures treatments for cancer and other viral infections and diseases. It is headquartered in Suzhou and has branches in Shanghai and Beijing. The company's founder, Chairman, and CEO, Dr.S.D. in Biophysics from the Chinese Academy of Sciences. He has over 20 years of experience in the development of innovative biologics and has served as Principal Investigator and Project Leader for Archemix, Serono, and Biogen. The company's self-developed technology platform includes a bispecific antibody development platform, a hybrid antibody development platform, and a biomolecule production platform. It also develops large molecule drugs and tumor immunotherapy, covering KN015, KN035, KN025, KN019 and other products. The company generates revenue by providing innovative oncology drugs and related services.
Who invested in Alphamab Oncology
7 investors across 2 rounds
See all investors in Alphamab Oncology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Alphamab Oncology
Who invested in Alphamab Oncology?
Alphamab Oncology has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Alphamab Oncology raised?
Alphamab Oncology has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Alphamab Oncology last raise money?
Alphamab Oncology's most recent round on record is a Series B, in May 2019.
What does Alphamab Oncology do?
Founded in 2015 and based in Jiangsu, China, Alphamab Oncology is a biopharmaceutical company that develops and manufactures treatments for cancer and other viral infections and diseases.
Where is Alphamab Oncology headquartered?
Alphamab Oncology is headquartered in Suzhou, China.
Which VCs invest in companies like Alphamab Oncology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Alphamab Oncology's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Alphamab Oncology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.